The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Kedei, N.,
Lewin, N. E.,
Selezneva, J.,
Braun, D. C.,
Che, J.,
Herrmann, M. A.,
Heldman, M. R.,
Lim, L.,
Mannan, P.,
Garfield, S. H.,
Poudel, Y. B.,
Cummins, T. J.,
Rudra, A.,
Blumberg, P. M.,
Keck, G. E.,
Géczy, T.:
Biological Profile of the Less Lipophilic and Synthetically More Accessible Bryostatin 7 Closely Resembles That of Bryostatin 1.
ACS Chem. Biol. 8 (4), 767-777, 2013.
Géczy, T.,
Peach, M.,
El Kazzouli, S.,
Sigano, D. M.,
Kang, J. H.,
Valle, C. J.,
Selezneva, J.,
Woo, W.,
Kedei, N.,
Lewin, N. E.,
Garfield, S. H.,
Lim, L.,
Mannan, P.,
Marquez, V. E.,
Blumberg, P. M.:
Molecular Basis for Failure of "Atypical" C1 Domain of Vav1 to Bind Diacylglycerol/Phorbol Ester.
J. Biol. Chem. 287 (16), 13137-13158, 2012.
Blumberg, P. M.,
Kedei, N.,
Lewin, N. E.,
Yang, D.,
Tao, J.,
Telek, A.,
Géczy, T.:
Phorbol Esters and Diacylglycerol: The PKC Activators.
In: Protein Kinase C in Cancer Signaling and Therapy. Ed.: Marcelo G. Kazanietz, Springer, New York, USA, 25-53, 2010. ISBN: 9781607615422
Bíró, T.,
Bodó, E.,
Telek, A.,
Géczy, T.,
Tychsen, B.,
Kovács, L.,
Paus, R.:
Hair cycle control by vanilloid receptor-1 (TRPV1): evidence from TRPV1 knockout mice.
J. Invest. Dermatol. 126 (8), 1909-1912, 2006.
Tóth, I. B.,
Géczy, T.,
Czifra, G.,
Seltmann, H.,
Paus, R.,
Kovács, L.,
Zouboulis, C. C.,
Bíró, T.:
The vanilloid receptor 1 (TRPV1) is expressed and functionally active on human SZ95 sebocytes.
J. Invest. Dermatol. 124 (4), A68, 2005.
